CN102406684B - Chinese medicinal preparation for treating traumatic hematoma - Google Patents

Chinese medicinal preparation for treating traumatic hematoma Download PDF

Info

Publication number
CN102406684B
CN102406684B CN201110388057.XA CN201110388057A CN102406684B CN 102406684 B CN102406684 B CN 102406684B CN 201110388057 A CN201110388057 A CN 201110388057A CN 102406684 B CN102406684 B CN 102406684B
Authority
CN
China
Prior art keywords
parts
chinese medicinal
weight
hematoma
medicinal preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110388057.XA
Other languages
Chinese (zh)
Other versions
CN102406684A (en
Inventor
宋爱民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cai Ailing
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201110388057.XA priority Critical patent/CN102406684B/en
Publication of CN102406684A publication Critical patent/CN102406684A/en
Application granted granted Critical
Publication of CN102406684B publication Critical patent/CN102406684B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention belongs to the field of Chinese medicinal preparations, in particular to a Chinese medicinal preparation for treating traumatic hematoma. The Chinese medicinal preparation is prepared from the following raw materials in parts by weight: 1 part of leech, 1 part of gadfly, 20 parts of artemisia anomala, 20 parts of eupolyphaga and 10 parts of pseudo-ginseng and has the functions of scattering stasis and diminishing swelling and relieving pain, quick-acting and high treatment effect on traumatic hematoma and no toxic or side effect and is safe and convenient.

Description

The Chinese medicine preparation for the treatment of traumatic hematoma
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of Chinese medicine preparation for the treatment of traumatic hematoma.
Background technology
Traumatic hematoma refer to the acute injuries such as women's head-ornaments, breast abdomen, extremity soft tissue or fracture, dislocation reset after a kind of symptom of scorching hot, the livid purple ecchymosis of local skin, swelling pain, limitation of activity, the primary disease commonly soft tissue such as muscular fascia, ligament is subject to suddenly the acute lacerated wound that excessive tractive causes because of External Force Acting.Its pathogenesis is that blood circulating out of vessels retardance meridians, QI-blood circulation are not smooth, and the traditional Chinese medical science adopts the principle for the treatment of such as dissipating blood stasis, reducing swelling and alleviating pain to obtain good therapeutic effect.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine preparation for the treatment of traumatic hematoma, has that determined curative effect, cure rate are high, a safe ready, the feature that has no side effect.
A kind of Chinese medicine preparation for the treatment of traumatic hematoma of the present invention, is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: 10 parts of 1 part of Hirudo, 1 part of Tabanus, 20 parts of Herba Artemisiae Anomalaes, 20 parts of eupolyphaga and Radix Notoginseng.
The present invention can make acceptable various preparations on Chinese materia medica, preferably decoction.
Preparation method: take raw material by above-mentioned weight, clean roguing, be ground into coarse grain, put in multi-function extractor, decoct with water 2 times, the decocting that adds for the first time 10 times of medical material gross weights boils 2 hours, filters to get filtrate, the decocting that adds up for the second time 7 times of weight of medical material boils 1 hour, filters; Twice filtrate is mixed, in heat-sealing bag, 100 DEG C of high temperature sterilizes, every bag of 200ml.
Usage and consumption: oral, every day, sooner or later respectively once each one bag 7 days was a course for the treatment of.
Drug action mechanism of the present invention is as follows:
Hirudo: removing blood stasis leads to the stasis of blood, the salty hardship of this product enters blood part, and merit is arrogated to oneself removing blood stasis, and the high effect of its power is grand, is usually used in the diseases such as blood stasis, amenorrhea and traumatic injury.
Tabanus: removing blood stasis, letting out property of this product hardship is strong, poisonous, specially enters Liver Channel blood system, energy removing blood stasis repercussive, promoting blood circulation.
Herba Artemisiae Anomalae: removing blood stasis is cured the wound, stimulated the menstrual flow, pain relieving, hemostasis, is usually used in traumatic injury in clinical and swells and ache, and this product energy blood-activating analgetic, hemostasis are cured the wound.
Eupolyphaga: removing blood stasis, reunion of fractured tendons and bones, this product is invigorated blood circulation and cured the wound, reunion of fractured tendons and bones is the product that traumatology is conventional, is usually used in treatment fracture grieved.
Radix Notoginseng: removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation, this product can be stopped blooding again can dissipating blood stasis, and there is hemostasis not stay the stasis of blood, hinder the stasis of blood and do not hinder positive feature, be traumatology key medicine.
Curative effect judgement:
Cure: hematoma all disappears, and whole body can be looked into without positive sign.
Take a turn for the better: hematoma major part disappears, and slightly feels pain.
Invalid: symptom and sign is without improvement.
Therapeutic outcome: clinical treatment traumatic hematoma 110 examples, oral medicine of the present invention, each 200ml that is grown up, sooner or later respectively once, child is cut down according to the circumstance, and within 7 days, is a course for the treatment of.The all courses of disease of indication women's head-ornaments, breast abdomen, extremity acute injury of soft tissue, swelling, the pain person in 2 weeks all can take.In one course for the treatment of, cure 88 examples, account for 80%, 17 examples that take a turn for the better, account for 15%, and invalid 5 examples, account for 5%, total effective rate 95%, and by without any side effects to patient shown in treatment, three large routine tests and hepatic and renal function detect no abnormal.
Below enumerate several model cases:
Case 1: patient Liu, man, 50 years old, get injured by a fall waist because falling down after drunk, hurt like hell, limitation of activity, oral pill for traumatic injuries treatment one week is invalid examined afterwards, gave to fully recover after the course for the treatment of of Drug therapy of the present invention, and activity is freely.Follow up a case by regular visits to 1 year without recurrence.
Case 2: patient king so-and-so, man, 19 years old, accidentally sprained left lower extremity ankle when playing basketball in May, 2008, local swelling, hurt like hell, limitation of activity, oral medicine of the present invention was fully recovered after the course for the treatment of.Follow up a case by regular visits to 1 year without recurrence.
Case 3: patient thanks so-and-so, man, 52 years old, during because of dry farm work, get injured by a fall right lower extremity, examine as right lower extremity muscle of leg lacerated wound at local hospital, give to fully recover after the course for the treatment of of Drug therapy of the present invention.Follow up a case by regular visits to 1 year without recurrence.
The present invention has the following advantages:
(1) Chinese herbal medicine used in the present invention all meets Pharmacopoeia of People's Republic of China regulation, and according to compatibility, the present invention has effect of dissipating blood stasis, reducing swelling and alleviating pain, is usually used in clinically traumatic hematoma.
(2) the present invention is applicable to the early treatment of traumatic hematoma, with vertical the answering of it proper its sound, has embodied the organic conception that the outer sick treatment by oral administration of medicines of the traditional Chinese medical science is local and whole body is unified.
(3) the present invention is nontoxic, harmless, and prescription is rigorous, science, the feature of efficient, short treating period, taking convenience.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.
Embodiment
Take by weight raw material: 10 parts of 1 part of Hirudo, 1 part of Tabanus, 20 parts of Herba Artemisiae Anomalaes, 20 parts of eupolyphaga and Radix Notoginseng.
Preparation method is to take raw material by above-mentioned weight, cleans roguing, is ground into coarse grain, puts in multi-function extractor, decoct with water 2 times, the decocting that adds for the first time 10 times of medical material gross weights boils 2 hours, filters to get filtrate, the decocting that adds up for the second time 7 times of weight of medical material boils 1 hour, filters; Twice filtrate is mixed, in heat-sealing bag, 100 DEG C of high temperature sterilizes, every bag of 200ml.

Claims (1)

1. treat a Chinese medicine preparation for traumatic hematoma, it is characterized in that being made by the raw material of following parts by weight: 10 parts of 1 part of Hirudo, 1 part of Tabanus, 20 parts of Herba Artemisiae Anomalaes, 20 parts of eupolyphaga and Radix Notoginseng;
Preparation method: take raw material by above-mentioned weight, clean roguing, be ground into coarse grain, put in multi-function extractor, decoct with water 2 times, the decocting that adds for the first time 10 times of medical material gross weights boils 2 hours, filters to get filtrate, the decocting that adds up for the second time 7 times of weight of medical material boils 1 hour, filters; Twice filtrate is mixed, in heat-sealing bag, 100 DEG C of high temperature sterilizes, every bag of 200ml.
CN201110388057.XA 2011-11-29 2011-11-29 Chinese medicinal preparation for treating traumatic hematoma Expired - Fee Related CN102406684B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110388057.XA CN102406684B (en) 2011-11-29 2011-11-29 Chinese medicinal preparation for treating traumatic hematoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110388057.XA CN102406684B (en) 2011-11-29 2011-11-29 Chinese medicinal preparation for treating traumatic hematoma

Publications (2)

Publication Number Publication Date
CN102406684A CN102406684A (en) 2012-04-11
CN102406684B true CN102406684B (en) 2014-07-02

Family

ID=45909222

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110388057.XA Expired - Fee Related CN102406684B (en) 2011-11-29 2011-11-29 Chinese medicinal preparation for treating traumatic hematoma

Country Status (1)

Country Link
CN (1) CN102406684B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863534A (en) * 1993-04-09 1999-01-26 Bio-Technology General Corp. Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity
CN1456256A (en) * 2003-02-20 2003-11-19 毛友昌 Compound pseudo-ginseng preparing method
WO2010053456A1 (en) * 2008-11-10 2010-05-14 Moleac Pte. Ltd. Combination therapy for treatment of patients with neurological disorders and cerebral infarction
CN102225076A (en) * 2011-06-14 2011-10-26 重庆时珍阁普生药业有限公司 Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863534A (en) * 1993-04-09 1999-01-26 Bio-Technology General Corp. Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity
CN1456256A (en) * 2003-02-20 2003-11-19 毛友昌 Compound pseudo-ginseng preparing method
WO2010053456A1 (en) * 2008-11-10 2010-05-14 Moleac Pte. Ltd. Combination therapy for treatment of patients with neurological disorders and cerebral infarction
CN102225076A (en) * 2011-06-14 2011-10-26 重庆时珍阁普生药业有限公司 Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
谢海州等.第十节 理血药.《简明中药手册》.山西科学技术出版社,1993,(第1版),第240-244页. *

Also Published As

Publication number Publication date
CN102406684A (en) 2012-04-11

Similar Documents

Publication Publication Date Title
CN100367985C (en) Chinese prepared medicine for treating bone pain
CN101352505B (en) Bone fracture setting medicine powder for treating traumatic injury
CN101757333A (en) External traditional Chinese medicament preparation for treating arthralgia
CN101708232A (en) Externally applied medicated wine for rheumatic ostalgia
CN102293853B (en) Chinese medicinal pills for treating Bi syndrome
CN103565969B (en) Traditional Chinese medicine composition for treating soft tissue injury and fracture
CN100484553C (en) External use medicine for treating knocks and falls, and joining bone
CN104857091A (en) Traditional Chinese medicine composition for treating renal calculus
CN104491642A (en) Foot bath powder for preventing and treating gout
CN102125664B (en) Chinese medicinal preparation for treating cervical spondylosis
CN103877157A (en) Chinese medicament for bone setting and preparation method of Chinese medicament
CN102406684B (en) Chinese medicinal preparation for treating traumatic hematoma
CN103768408B (en) A kind of medicine preventing and treating anal and intestinal disease postoperative pain
CN103638116B (en) The auxiliary natural herbal mixture of a kind of synthetism
CN105748841A (en) Medicine for treating burns and scalds and preventing healed scar formation and preparation method thereof
CN102784355B (en) First-aid drug and preparation method thereof
CN102125612B (en) Chinese medicinal preparation for treating acute lumbar sprain
CN104083421A (en) Traditional Chinese medicine ointment for treating bedsore and preparation method thereof
CN103028022B (en) Traditional Chinese medicine composition for treating arthralgia
CN102204966B (en) Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain
CN105748801A (en) Medicine for removing scars and preparing method thereof
CN105267318A (en) Chinese patent medicine for eliminating ostealgia
CN104491215B (en) A kind of Chinese medicine for treating flaccid paralysis
CN103735868B (en) A kind of preparation method of anal and intestinal disease postoperative bag
CN109939157A (en) A kind of liquid medicine and plaster for treating rheumatism, soft tissue injury initiation pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Cai Ailing

Inventor before: Song Aimin

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20170515

Address after: 061000 Cangzhou city of Hebei province Xianxian County Linhe Xi Yin Guan Cun, No. 150

Patentee after: Cai Ailing

Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China

Patentee before: Song Aimin

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140702

Termination date: 20171129

CF01 Termination of patent right due to non-payment of annual fee